54 related articles for article (PubMed ID: 8814238)
1. Abnormality of Oct-1 DNA binding in T cells from Sjögren's syndrome patients.
Flescher E; Vela-Roch N; Ogawa N; Nakabayashi T; Escalante A; Anaya JM; Dang H; Talal N
Eur J Immunol; 1996 Sep; 26(9):2006-11. PubMed ID: 8814238
[TBL] [Abstract][Full Text] [Related]
2. Severe combined immunodeficiency due to defective binding of the nuclear factor of activated T cells in T lymphocytes of two male siblings.
Feske S; Müller JM; Graf D; Kroczek RA; Dräger R; Niemeyer C; Baeuerle PA; Peter HH; Schlesier M
Eur J Immunol; 1996 Sep; 26(9):2119-26. PubMed ID: 8814256
[TBL] [Abstract][Full Text] [Related]
3. Abnormalities in peripheral B cell memory of patients with primary Sjögren's syndrome.
Hansen A; Gosemann M; Pruss A; Reiter K; Ruzickova S; Lipsky PE; Dörner T
Arthritis Rheum; 2004 Jun; 50(6):1897-908. PubMed ID: 15188366
[TBL] [Abstract][Full Text] [Related]
4. The B cell coactivator Bob1 shows DNA sequence-dependent complex formation with Oct-1/Oct-2 factors, leading to differential promoter activation.
Gstaiger M; Georgiev O; van Leeuwen H; van der Vliet P; Schaffner W
EMBO J; 1996 Jun; 15(11):2781-90. PubMed ID: 8654375
[TBL] [Abstract][Full Text] [Related]
5. Development of autoimmune arthritis with aging via bystander T cell activation in the mouse model of Sjögren's syndrome.
Kobayashi M; Yasui N; Ishimaru N; Arakaki R; Hayashi Y
Arthritis Rheum; 2004 Dec; 50(12):3974-84. PubMed ID: 15593201
[TBL] [Abstract][Full Text] [Related]
6. Basis for defective proliferation of peripheral blood T cells to anti-CD2 antibodies in primary Sjögren's syndrome.
Gerli R; Bertotto A; Agea E; Lanfrancone L; Cernetti C; Spinozzi F; Rambotti P
J Clin Invest; 1990 Dec; 86(6):1870-7. PubMed ID: 1979333
[TBL] [Abstract][Full Text] [Related]
7. Immunoregulation in Sjögren's syndrome: influence of serum factors on T-cell subpopulations.
Moutsopoulos HM; Fauci AS
J Clin Invest; 1980 Feb; 65(2):519-28. PubMed ID: 6444308
[TBL] [Abstract][Full Text] [Related]
8. Brain-derived neurotrophic factor and nerve growth factor correlate with T-cell activation in primary Sjogren's syndrome.
Fauchais AL; Boumediene A; Lalloue F; Gondran G; Loustaud-Ratti V; Vidal E; Jauberteau MO
Scand J Rheumatol; 2009; 38(1):50-7. PubMed ID: 18830907
[TBL] [Abstract][Full Text] [Related]
9. Octamer proteins inhibit IL-4 gene transcription in normal human CD4 T cells.
Cron RQ; Zhou B; Brunvand MW; Lewis DB
Genes Immun; 2001 Dec; 2(8):464-8. PubMed ID: 11781715
[TBL] [Abstract][Full Text] [Related]
10. Binding of nuclear proteins to the negative regulatory element of the IL-2 gene in lymphocytes from rheumatic patients.
Flescher E; Vela-Roch N; Talal N; Dang H
Cytokine; 1999 Mar; 11(3):187-91. PubMed ID: 10209065
[TBL] [Abstract][Full Text] [Related]
11. Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome.
Ogawa N; Ping L; Zhenjun L; Takada Y; Sugai S
Arthritis Rheum; 2002 Oct; 46(10):2730-41. PubMed ID: 12384933
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 2 defect in the peripheral blood and the lung in patients with Sjögren's syndrome.
Miyasaka N; Murota N; Yamaoka K; Sato K; Yamada T; Nishido T; Okuda M
Clin Exp Immunol; 1986 Sep; 65(3):497-505. PubMed ID: 3490935
[TBL] [Abstract][Full Text] [Related]
13. Comparison of antinuclear antibody and other immunohematological profiles among primary Sjögren's syndrome, secondary Sjögren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease.
Ichikawa Y; Takaya M; Shimizu H; Uchiyama M; Moriuchi J; Morita K; Hoshina Y; Horiki T
Tokai J Exp Clin Med; 1993 Dec; 18(3-6):133-8. PubMed ID: 7701526
[TBL] [Abstract][Full Text] [Related]
14. Biochemical deficiency of pyridoxine does not affect interleukin-2 production of lymphocytes from patients with Sjögren's syndrome.
Tovar AR; Gómez E; Bourges H; Ortíz V; Kraus A; Torres N
Eur J Clin Nutr; 2002 Nov; 56(11):1087-93. PubMed ID: 12428174
[TBL] [Abstract][Full Text] [Related]
15. T cell reactivity to Sjögren's syndrome related antigen La(SSB).
Helsloot J; Sturgess A
J Rheumatol; 1997 Dec; 24(12):2340-7. PubMed ID: 9415639
[TBL] [Abstract][Full Text] [Related]
16. Correlation of increased susceptibility to apoptosis of CD4+ T cells with lymphocyte activation and activity of disease in patients with primary Sjögren's syndrome.
Zeher M; Szodoray P; Gyimesi E; Szondy Z
Arthritis Rheum; 1999 Aug; 42(8):1673-81. PubMed ID: 10446867
[TBL] [Abstract][Full Text] [Related]
17. Identification of sites for distinct DNA binding proteins including Oct-1 and Oct-2 in the Cr2 gene.
Christensen SM; Martin BK; Tan SS; Weis JH
J Immunol; 1992 Jun; 148(11):3610-7. PubMed ID: 1534100
[TBL] [Abstract][Full Text] [Related]
18. Oct-1 transcription factor is a negative regulator of rat CYP1A1 expression via an octamer sequence in its negative regulatory element.
Sterling K; Bresnick E
Mol Pharmacol; 1996 Feb; 49(2):329-37. PubMed ID: 8632766
[TBL] [Abstract][Full Text] [Related]
19. [Cell-mediated immunity in patients with Sjogren's syndrome].
Krejsek J; Slezák R; Kopecký O; Vokurková D; Loudová M; Derner V
Cas Lek Cesk; 1997 Jan; 136(2):44-7. PubMed ID: 9147852
[TBL] [Abstract][Full Text] [Related]
20. IgA and IgG autoantibodies against alpha-fodrin as markers for Sjögren's syndrome. Systemic lupus erythematosus.
Witte T; Matthias T; Arnett FC; Peter HH; Hartung K; Sachse C; Wigand R; Braner A; Kalden JR; Lakomek HJ; Schmidt RE
J Rheumatol; 2000 Nov; 27(11):2617-20. PubMed ID: 11093442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
